Case Studies  /  Market Access and Reimbursement

Evaluating innovative contracting and reimbursement for emerging gene therapy


Acquiring company sought to probe the reimbursement landscape and innovative contracting considerations for a gene therapy in development.


  • Evaluated current payer practices to manage orphan therapies
  • Interviewed senior payer and policy executives to assess unmet needs perceptions, likely utilization management, and potential financing mechanisms
  • Developed case studies of analog examples
  • Benchmarked target asset relative to several other competitors


  • Advised client concerning value proposition, budget impact, pricing and contracting considerations and CMS engagement
  • Client used input to inform imminent acquisition and market access strategy

© 2023 Opus Strategy, LLC